Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Liver Transplantation”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06019507
What this trial is testing

TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

Who this might be right for
Liver Transplantation
ITB-Med LLC 12
Not applicableNot Yet RecruitingNCT07204600
What this trial is testing

Prevalence & Risk Factors of De Novo (MASLD) Post Liver Transplant

Who this might be right for
Post Liver Tranзplant
Assiut University 100
Post-approval studies (Phase 4)Study completedNCT03619837
What this trial is testing

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Who this might be right for
Hepatitis CTransplantation Disease Transmission
University of California, San Francisco 122
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Testing effectiveness (Phase 2)UnknownNCT00890253
What this trial is testing

Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

Who this might be right for
Liver TransplantationChronic Renal Insufficiency
Armin Goralczyk 29
Large-scale testing (Phase 3)Study completedNCT00328770
What this trial is testing

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Liver Carcinoma
University of Alberta 70
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Early research (Phase 1)Study completedNCT00545259
What this trial is testing

Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation

Who this might be right for
de Novo Liver Transplantation
Novartis 13
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Post-approval studies (Phase 4)Study completedNCT00149994
What this trial is testing

Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 171
Large-scale testing (Phase 3)Study completedNCT01625377
What this trial is testing

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 188
Post-approval studies (Phase 4)Active Not RecruitingNCT04720326
What this trial is testing

Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

Who this might be right for
Prophylaxis Against Liver Transplant Rejection
Edward Geissler 268
Large-scale testing (Phase 3)Study completedNCT03241043
What this trial is testing

Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Universitätsklinikum Hamburg-Eppendorf 20
Post-approval studies (Phase 4)Looking for participantsNCT05242315
What this trial is testing

Extended-Release Tacrolimus Following Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more
University of Alberta 94
Testing effectiveness (Phase 2)UnknownNCT01423708
What this trial is testing

Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

Who this might be right for
Liver FailureLiver DiseasesLiver Cirrhosis+1 more
Azienda Ospedaliera di Padova 117
Post-approval studies (Phase 4)Study completedNCT01371331
What this trial is testing

Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Who this might be right for
Kidney TransplantationHeart TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 52
Large-scale testing (Phase 3)Study completedNCT00622869
What this trial is testing

Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 719
Post-approval studies (Phase 4)Study completedNCT00332462
What this trial is testing

Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 34
Large-scale testing (Phase 3)Ended earlyNCT00284921
What this trial is testing

MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

Who this might be right for
De Novo Kidney Transplant
Novartis Pharmaceuticals 60
Load More Results